Risk Assessment Report on Chlorine. Human Health Part. CAS No.: EINECS No

Similar documents
Risk Assessment Report on sodium hypochlorite Human Health Part. CAS No.: EINECS No

Opinion on. Risk Assessment Report on NITROBENZENE. Human Health Part. CAS No: EINECS No:

Risk Assessment Report on Hexachlorocyclopentadiene (HCCP) Human Health Part. CAS No.: EINECS No.:

Opinion on. Risk Assessment Report on TETRACHLOROETHYLENE Human Health Part. CAS No.: EINECS No

Risk Assessment Report on styrene. Human Health Part

Opinion on Voluntary Risk Assessment Report on lead and lead compounds. Human Health Part

Risk Assessment Report on. Bis(hydroxylammonium)sulfate. CAS No.: EINECS no.:

Risk Assessment Report on Vinyl acetate. Human Health Part. CAS No.: EINECS No.:

Risk Assessment Report on Alkanes, C 14-17, chloro MCCP. Human Health Part. CAS No.: EINECS no.:

Risk Assessment Report on Diphenylamine. Human Health Part. CAS No.: EINECS No.:

Assessment of the Health Risks from the Use of Metallic Nickel (CAS No ) in Toys

TARGETED RISK ASSESSMENT REPORT ON SODIUM HYDROXIDE (NAOH) HUMAN HEALTH PART. CAS No.: ; EINECS No.:

Clarification on the Opinions SCCNFP/0653/03 and SCCP/0882/05

Risk Assessment Report on Tris (nonylphenyl)phosphite (TNPP)

Risk Assessment Report on Zinc. Environmental Part

SCIENTIFIC COMMITTEE ON TOXICITY, ECOTOXICITY AND THE ENVIRONMENT (CSTEE) Opinion on the results of the Risk Assessment of:

Scientific Committee on Consumer Products SCCP OPINION ON. Toluene. (its use as a solvent in nail cosmetics)

Risk Assessment Terminology, Expression of Nature and level of Risk and Uncertainties

Draft OPINION ON. Use of the Threshold of Toxicological Concern (TTC) Approach for the Safety Assessment of Chemical Substances

HYDROGEN PEROXIDE HUMAN HEALTH EFFECTS. CAS No.: EINECS No.: REPORT VERSION: Draft of 24 April 2001

Biocidal Products Committee (BPC)

Opinion on. Classification of Musk ketone

Biocidal Products Committee (BPC)

Risk Assessment to Risk Management Terminology of Risk Assessment. EFSA Project on Risk Assessment Terminology

DRAFT COMMISSION DELEGATED REGULATION (EU) /... of XXX

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Joint meetrag of the Earopean Commission Scieatäfíc Committees and the Еигореав

EFSA Statement regarding the EU assessment of glyphosate and the socalled

Biocidal Products Committee (BPC)

Biocidal Products Committee (BPC)

Opinion on an Annex XV dossier proposing restrictions on Dimethylfumarate (DMFu)

Annex XV. 2,4 - Dinitrotoluene

Please find below the Commission Communication and the Commission Recommendation for the substance zinc sulphate

Human health effects of antimony an update

SCIENTIFIC COMMITTEE ON TOXICITY, ECOTOXICITY AND THE ENVIRONMENT (CSTEE)

COMMISSION REGULATION (EU)

Questions and Answers on Candidates for Substitution

Trisodium nitrilotriacetate (NTA)

COMMISSION REGULATION (EU) / of XXX

HUMAN HEALTH RISK ASSESSMENT FOR METALLIC CHROMIUM AND TRIVALENT CHROMIUM IN ACCORDANCE WITH EUROPEAN UNION LEGISLATION

Room: 0D Centre Albert Borschette Rue Froissart Brussels, Belgium

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.

FÜR RISIKOBEWERTUNG BUNDESINSTITUT

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Held on 20 September 2005 in Brussels MINUTES

Scientific Committee on Health and Environmental Risks SCHER

All member States were represented, except Bulgaria and Czech Republic

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.

SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 10 DECEMBER 2012 (Section General Food Law)

EU-Funded Research on EMF and Health'

Scientific Committee on Health and Environmental Risks SCHER

Non surfactant Organic Ingredients and Zeolite-based Detergents

Schmallenberg virus: Risk Management and Control Strategy in the EU

Benzothiazole-2-thiol (2-MBT)

Biocidal Products Committee (BPC)

SCIENTIFIC COMMITTEE ON TOXICITY, ECOTOXICITY AND THE ENVIRONMENT (CSTEE) Minutes of the. 29th PLENARY MEETING

Pesticide risk assessment: changes and perspectives for mammalian toxicology in the new EC regulation 1107/2009

TRIS (NONYLPHENYL) PHOSPHITE SUMMARY RISK ASSESSMENT REPORT

Special Report: How Your Shower May Be Hazardous To Your Health! By Joel Kaye, MA

Health & Consumer Protection. EC legislation on food. Olga Solomon Unit E3

PRODUCT INFORMATION SHEET

Opinion on the Risk from the Use of Diantimony Trioxide in Toys

Biocidal Products Committee (BPC)

Addendum to the 12th Report on Carcinogens

An example of intersectoral collaboration: the EU model. European Commission Health and Consumers Directorate-General (DG SANCO)

SAFETY DATA SHEET according to 1907/2006/EC, Article 31

ECPA position paper on the criteria for the determination of endocrine disrupting properties under Regulation

PUBLIC CONSULTATION DOCUMENT

Product Stewardship Summary

Annex to a news release

Scientific Committee on Health and Environmental Risks SCHER. Scientific Committee on Emerging and Newly Identified Health Risks SCENIHR

COMMISSION REGULATION (EU) No /.. of XXX

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) GUIDELINE ON USER SAFETY FOR IMMUNOLOGICAL VETERINARY MEDICINAL PRODUCTS

Dental amalgams & alternative materials

CLEANPRO APPLIANCE DESCALER

Official Journal of the European Union. (Non-legislative acts) REGULATIONS

SCIENTIFIC PANEL ON FOOD CONTACT MATERIALS, ENZYMES, FLAVOURINGS AND PROCESSING AIDS (CEF) Parma, 05 December 2011.

Official Journal of the European Union

European Food Safety Authority (EFSA)

Material Safety Data Sheet

MHE Position on the EC Green Paper on Mental Health An EU Strategy on Mental Health and Well Being

Food additives and nutrient sources added to food: developments since the creation of EFSA

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT. Accompanying document to the

Risk Assessment Issues: Asbestos p. 100 Review of Epidemiological Evidence for Health Effects in Workers Exposed to MMMFs p. 103

Passive Smoking from a Human Rights Perspectives

Practical guidance for applicants on the submission of applications on food additives, food enzymes and food flavourings

Trilateral meeting on perchlorate risk assessment Trilateral meeting report of the meeting on , Parma. (Agreed on )

SAFETY DATA SHEET NON VOC THIXOTROPIC GEL 1 LITRE

EUROPEAN COMMISSION DG Employment, Social Affairs and Inclusion. The Advisory Committee on Safety and Health at Work. Supplementary Opinion

COMMISSION REGULATION (EU) / of XXX

Procedural advice on publication of information on withdrawals of applications related to the marketing authorisation of human medicinal products

SILICA, CRYSTALLINE (RESPIRABLE DUST)

Committee for Risk Assessment (RAC)

Guidance on the review, revision and development of EFSA s cross-cutting guidance documents

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.

HENNA POWDER Date: 1/18/17

Material Safety Data Sheet (EU)

COMMISSION REGULATION (EU) / of XXX

Transcription:

Scientific Committee on Health and Environmental Risks SCHER Risk Assessment Report on Chlorine Human Health Part CAS No.: 7782-50-5 EINECS No. 231-959-5 The SCHER adopted this opinion at its 22 nd plenary on 12 March 2008

About the Scientific Committees Three independent non-food Scientific Committees provide the Commission with the scientific advice it needs when preparing policy and proposals relating to consumer safety, public health and the environment. The Committees also draw the Commission's attention to the new or emerging problems which may pose an actual or potential threat. They are: the Scientific Committee on Consumer Products (SCCP), the Scientific Committee on Health and Environmental Risks (SCHER) and the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) and are made up of external experts. In addition, the Commission relies upon the work of the European Food Safety Authority (EFSA), the European Medicines Evaluation Agency (EMEA), the European Centre for Disease prevention and Control (ECDC) and the European Chemicals Agency (ECHA). SCHER Questions relating to examinations of the toxicity and ecotoxicity of chemicals, biochemicals and biological compounds whose use may have harmful consequences for human health and the environment. In particular, the Committee addresses questions related to new and existing chemicals, the restriction and marketing of dangerous substances, biocides, waste, environmental contaminants, plastic and other materials used for water pipe work (e.g. new organics substances), drinking water, indoor and ambient air quality. It addresses questions relating to human exposure to mixtures of chemicals, sensitisation and identification of endocrine disrupters. Scientific Committee members Herman Autrup, Peter Calow, Wolfgang Dekant, Helmut Greim, Hanke Wojciech, Colin Janssen, Bo Jansson, Hannu Komulainen, Ole Ladefoged, Jan Linders, Inge Mangelsdorf, Marco Nuti, Anne Steenhout, Jose Tarazona, Emanuela Testai, Marco Vighi, Matti Viluksela Contact: European Commission Health & Consumer Protection DG Directorate C: Public Health and Risk Assessment Unit C7 - Risk Assessment Office: B232 B-1049 Brussels Sanco-Sc8-Secretariat@ec.europa.eu European Commission 2008 The opinions of the Scientific Committees present the views of the independent scientists who are members of the committees. They do not necessarily reflect the views of the European Commission. The opinions are published by the European Commission in their original language only. http://ec.europa.eu/health/ph_risk/risk_en.htm 2

ACKNOWLEDGMENTS The rapporteur is acknowledged for her valuable contribution to this opinion: Prof. W. Dekant Universität Würzburg, Germany Keywords: SCHER, scientific opinion, risk assessment, Regulation 793/93, chlorine, human health, CAS 7782-50-5 Opinion to be cited as: SCHER, scientific opinion on the risk assessment report on chlorine, human health part, CAS 7782-50-5, 12 March 2008 3

TABLE OF CONTENTS ACKNOWLEDGMENTS... 3 1. BACKGROUND... 5 2. TERMS OF REFERENCE... 5 3. OPINION... 5 3.1 General comments... 5 3.2 Specific comments... 5 3.2.1 Exposure assessment... 5 3.2.2 Effect assessment... 5 3.2.3 Risk characterisation... 6 4. LIST OF ABBREVIATIONS... 6 4

1. BACKGROUND Council Regulation 793/93 provides the framework for the evaluation and control of the risk of existing substances. Member States prepare Risk Assessment Reports on priority substances. The Reports are then examined by the Technical Committee under the Regulation and, when appropriate, the Commission invites the Scientific Committee on Health and Environmental Risks (SCHER) to give its opinion. 2. TERMS OF REFERENCE On the basis of the examination of the Risk Assessment Report the SCHER is invited to examine the following issues: (1) Does the SCHER agree with the conclusions of the Risk Assessment Report? (2) If the SCHER disagrees with such conclusions, it is invited to elaborate on the reasons. (3) If the SCHER disagrees with the approaches or methods used to assess the risks, it is invited to suggest possible alternatives. 3. OPINION 3.1 General comments The health part of the document is of good quality, it is comprehensive, and the exposure and effects assessment follow the Technical Guidance Document. The RAR covers all studies relevant for exposure and hazard assessment of chlorine. 3.2 Specific comments 3.2.1 Exposure assessment Chlorine is used as an intermediate in a large number of synthetic processes in industrial chemistry. It is also used for disinfection of drinking water and swimming pools. Due to its wide-spread use, well justified occupational exposure limits for chlorine are available. Regarding occupational exposure assessment, the RAR relies on the large number of data available measuring air concentrations of chlorine in occupational settings. Based on these data, representative exposure scenarios can easily be derived. SCHER agrees that dermal exposures under occupational exposure conditions are not relevant and that consumer exposure and indirect exposures should not be considered due to the high reactivity and the short half-life of chlorine. 3.2.2 Effect assessment The RAR describes in detail all the toxicity studies performed with chlorine and also references to studies performed with hypochloride, which is formed from chlorine in aqueous solutions. Regarding repeated-dose toxicity, a number of studies are available for evaluation and SCHER agrees with NOAECs derived from the evaluation of these studies. The target organ for chlorine toxicity after inhalation is the respiratory tract in animals. Accidental exposures of humans to chlorine also confirm that the respiratory tract is a target for chlorine toxicity in humans. SCHER agrees that there is no concern regarding carcinogenicity of chlorine since a guideline-conforming inhalation study in rodents without increases in tumour incidences in chlorine exposed groups has been performed. Regarding reproductive toxicity only studies relating to oral exposures to chlorine with drinking water are available. These studies are negative. Inhalation exposures to chlorine 5

will unlikely result in reproductive toxicity due to the high reactivity of chlorine in the respiratory tract and its rapid transformation. 3.2.3 Risk characterisation The risk characterization performed in the RAR uses the MOS approach for inhalation exposures of workers. The SCHER agrees with conclusion ii) 1 for all occupational scenarios as concluded in the RAR. The NOAEC derived in the RAR is identical to the occupational exposure limit in a number of EU-members. Therefore, SCHER is of the opinion that application of a MOS to a health-based occupational exposure limit is not necessary. 4. LIST OF ABBREVIATIONS MOS NOAEC RAR TGD Margin of Safety No Observed Adverse Effect Concentration Risk Assessment Report Technical Guidance Document 1 According to the Technical Guidance Document on Risk Assessment European Communities 2003: - conclusion i): There is a need for further information and/or testing; - conclusion ii): There is at present no need for further information and/or testing and for risk reduction measures beyond those which are being applied already; - conclusion iii): There is a need for limiting the risks; risk reduction measures which are already being applied shall be taken into account. 6